AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
Advocating for veterinary patients’ pharmaceutical needs
The AVMA works with policymakers to advocate for sensible pharmaceutical rules that recognize the unique and important needs of veterinary medicine,…
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
JAVMA news
International veterinary leaders speak of shared mission
International veterinary leaders speak of shared mission Dr. Robert Baker The AVMA is not…
AVMA news
AVMA members press Congress for illicit xylazine, dog importation laws
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged…
AVMA news
NIH program in canine comparative oncology marks 20 years of progress
The National Institutes of Health created the Comparative Oncology Program two decades ago to advance the study of naturally occurring cancer in dogs,…
JAVMA news
National associations join forces to explore common goals
National associations join forces to explore common goals The AVMA will join forces with the Australian, British, and …
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Cultivating research on cancer in dogs, from clinical trials down to the molecular level
The Comparative Oncology Program at the National Institutes of Health, which promotes the study of cancer in dogs, manages the Comparative Oncology…
AVMA news
Catalyzing the field of canine comparative oncology, benefiting researchers far and wide
The Comparative Oncology Program at the National Institutes of Health has transformed canine comparative oncology since the program’s founding 20…
AVMA news
Unregulated horse racing continues to pose risks
A persistent and potentially growing concern, according to experts, is the running of unsanctioned, informal horse races. Unregulated horse racing is…
JAVMA news
USDA launches Web site on food safety research programs
USDA launches Web site on food safety research programs
AVMA news
WVC features AVMA sessions, research results
The AVMA offered sessions at the 2023 WVC Annual Conference as part of a year-old partnership with Viticus Group, the organization that hosts WVC.…
AVMA news
VMX 2023 draws a crowd for 40th anniversary
Several new studies were unveiled at @the_NAVC Veterinary Meeting & Expo this January in Orlando, Florida, including research identifying 30 different…
JAVMA news
Alternatives for controlling animal pain
Holistic medicine is becoming increasingly common in human health care.
JAVMA news
AASV guiding members around black holes, in new directions - April 15, 2001
AASV guiding members around black holes, in new directions The American Association of Swine Veterinarians imparted